US SB4640 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on September 22 2020 - 25% progression, died in committee
Action: 2020-09-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requires prescribers of controlled substances, as a condition of obtaining or renewing their registration with the Drug Enforcement Administration, to complete specified education or training on the prevention, treatment, and management of opioid-use and other substance-use disorders. This education and training shall also satisfy the training requirements currently needed to obtain waivers to prescribe certain medication-assisted treatments for opioid-use disorders in settings other than opioid treatment programs.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

MATE Act of 2020 Medication Access and Training Expansion Act of 2020

Sponsors


History

DateChamberAction
2020-09-22SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB4974 (Related) 2019-12-18 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Subjects


US Congress State Sources


Bill Comments

feedback